Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3034099	li-cmvab	— (—)	78	83	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Bacterial infection, other or unspecified, including avohilmo

9.83

23.62

1.1

1.0

—

Bacterial infection, other or unspecified

9.91

21.68

1.1

1.0

—

ILD medications: immunosuppressive drugs

8.47

21.60

1.1

—

Fever of other and unknown origin

9.00

20.57

1.1

1.0

—

Other bacterial diseases

6.43

17.53

1.1

1.0

—

Oral corticosteroids

6.20

17.42

1.1

—

Pneumonia, organism unspecified

6.25

15.87

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

6.09

15.39

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

5.46

14.30

1.1

—

Inflammatory bowel disease treatment related agents

5.25

14.26

1.1

—

Influenza and pneumonia

5.36

13.99

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

5.36

13.92

1.1

—

All pneumoniae

5.19

13.48

1.1

—

Autoimmune diseases excluding thyroid diseases

5.42

13.33

1.1

—

L04AX Other immunosuppressants

5.75

12.69

1.1

—

Second line medication for Crohn's disease

5.75

12.68

1.1

—

Other bacterial diseases, including avohilmo

5.06

12.12

1.1

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

5.45

11.81

1.1

—

5.45

11.81

1.1

—

Visual disturbances and blindness

5.83

11.75

1.0

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

5.10

11.49

1.1

—

ILD medications

4.75

10.68

1.1

—

Senile cataract

6.08

10.43

1.0

1.1

—

Disorders of lens

5.71

10.41

1.0

1.2

—

Autoimmune diseases related-to ILD

4.43

10.17

1.0

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4.25

10.01

1.1

1.0

—

Persons encountering health services for specific procedures and health care

4.21

9.75

1.1

1.0

—

First line medication for Crohn's disease

4.56

9.57

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4.78

9.55

1.0

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

15.01

9.50

1.0

—

Focal epilepsy

17.51

9.38

1.1

1.0

—

Epilepsy

10.60

9.24

1.1

1.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

16.27

8.54

1.2

1.0

—

Focal epilepsy, strict definition

16.27

8.54

1.2

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

3.92

8.46

1.0

1.1

—

Implicit Sepsis

4.34

8.45

1.1

—

Liquid cancers, including Hilmo

7.56

7.98

1.0

1.1

—

Presence of other functional implants

4.72

7.86

1.0

1.1

—

Any death

4.51

7.55

1.0

1.2

—

Implicit Sepsis, including avohilmo

3.91

7.38

1.1

1.0

—

Diagnoses used for exclusion with ILD

10.84

7.28

1.1

1.0

—

Cerebrovascular diseases

4.01

7.22

1.1

—

Other and unspecified polyneuropathies, also in other diseases

12.01

7.07

1.0

—

Implicit viral Sepsis

13.76

6.88

1.1

1.0

—

Viral Sepsis

13.76

6.88

1.1

1.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

10.92

6.78

1.0

—

Implicit bacterial Sepsis

6.34

6.76

1.2

1.0

—

Liquid cancers

8.28

6.76

1.0

1.1

—

Heart failure, not strict

3.92

6.64

1.0

1.1

—

Cerebrovascular diseases (FINNGEN)

10.12

6.53

1.2

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

3.52

6.47

1.1

—

Implicit bacterial Sepsis, including avohilmo

5.89

6.40

1.2

1.0

—

Other disorders of lacrimal gland

7.37

6.40

1.0

1.1

—

Bacterial Sepsis

5.86

6.37

1.2

1.0

—

L04AA Selective immunosuppressants

11.01

6.29

1.0

—

General symptoms and signs

3.94

6.25

1.1

1.0

—

Reimbursement for rheumatic diseases

3.93

6.09

1.1

—

Disorders of eyelid, lacrimal system and orbit

3.43

6.00

1.0

1.1

—

Low back pain

3.75

6.00

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

3.46

5.98

1.1

1.0

—

Oedema, not elsewhere classified

8.37

5.94

1.1

1.0

—

Renal tubulo-interstitial diseases

3.30

5.94

1.0

1.1

—

Metabolic disorders

3.57

5.93

1.0

1.1

—

Asthma (mode)

4.94

5.92

1.1

—

Autoimmune diseases

3.54

5.77

1.0

1.1

—

Septicaemia

6.38

5.76

1.1

—

Visual disturbances

4.86

5.72

1.0

1.1

—

Care involving use of rehabilitation procedures

4.00

5.70

1.1

—

Other septicaemia

6.81

5.65

1.1

1.0

—

Other septicaemia, including avohilmo

6.78

5.63

1.1

1.0

—

Disorders of lacrimal system

5.47

5.58

1.0

—

Biological medication for rheuma

12.87

5.57

1.1

1.0

—

Mycoses

8.47

5.55

1.2

1.0

—

Explicit Sepsis

5.46

5.51

1.1

1.0

—

Explicit Sepsis, including avohilmo

5.44

5.49

1.1

1.0

—

Implicit viral Sepsis, including avohilmo

7.05

5.42

1.1

1.0

—

Other symptoms and signs involving cognitive functions and awareness

5.32

5.38

1.1

—

Other neurological diseases

3.43

5.28

1.0

1.1

—

Asthma-related infections

3.53

5.24

1.0

1.1

—

Asthma, hospital admission 2, infections

3.53

5.24

1.0

1.1

—

Pure hypercholesterolaemia

3.85

5.19

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

4.53

5.11

1.2

1.0

—

Codes for special purposes

4.53

5.11

1.2

1.0

—

Asthma

4.55

5.08

1.1

—

L04AD Calcineurin inhibitors

13.35

5.07

1.1

1.0

—

Certain disorders involving the immune mechanism

13.34

5.07

1.1

1.0

—

Lung diseases due to external agents

13.35

5.07

1.0

—

Candidiasis, including avohilmo

8.34

5.05

1.1

—

Covid-19 confirmed case

5.65

5.04

1.2

1.0

—

Renal failure

4.54

5.01

1.0

1.1

—

Dorsalgia

3.24

4.99

1.1

—

Sleep apnoea

3.02

4.98

1.1

—

Other viral diseases

6.85

4.93

1.1

—

Bacterial pneumoniae

6.20

4.90

1.0

1.1

—

Polyarthropathies

3.50

4.88

1.0

1.1

—

Asthma, unspecified (mode), excluding more controls

5.81

4.85

1.1

—

Dysphagia

7.70

4.84

1.0

1.1

—

Chronic kidney disease

5.21

4.74

1.0

—

STROKE

3.88

4.73

1.1

—

Asthma, unspecified (mode)

5.52

4.69

1.1

—

All chronic kidney diseases

3.62

4.56

1.0

1.1

—

Acute and subacute iridocyclitis

8.19

4.55

1.1

1.0

—

Anterior Iridocyclitis

8.19

4.55

1.1

1.0

—

Type 2 diabetes, wide definition

3.34

4.55

1.0

1.1

—

Malaise and fatigue

5.12

4.52

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

10.01

4.51

1.0

—

Symptoms and signs involving speech and voice

6.67

4.46

1.0

1.1

—

Bacterial pneumonia, not elsewhere classified

6.04

4.46

1.0

1.1

—

Other cataract

5.08

4.45

1.1

1.2

—

Missing teeth due to accident, extraction or parodontitis

3.32

4.45

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

3.00

4.40

1.1

1.0

—

4.34

4.39

1.0

1.1

—

Other diseases of blood and blood-forming organs, wide

7.51

4.35

1.2

1.0

—

Asthma (only as main-diagnosis), excluding more controls

4.84

4.31

1.0

1.1

—

Asthma-related pneumonia

4.98

4.29

1.0

1.1

—

Asthma-related pneumonia or sepsis

4.98

4.29

1.0

1.1

—

Asthma, hospital admissions 3, pneumonia

4.98

4.29

1.0

1.1

—

Other viral diseases, including avohilmo

4.95

4.27

1.1

—

Diabetes, varying definitions

2.90

4.19

1.0

1.1

—

Asthma (only as main-diagnosis)

4.60

4.16

1.0

1.1

—

Iridocyclitis

6.93

4.16

1.1

—

Diabetes mellitus

2.89

4.15

1.0

1.1

—

Systemic connective tissue disorders

5.24

4.13

1.1

—

Headache

4.16

4.07

1.0

—

Bacterial pneumonia (organism specified)

4.72

4.06

1.0

1.1

—

Subjective visual disturbances

8.00

4.05

1.0

—

Neurological diseases

5.48

4.01

1.0

—

Dialysis, with operation codes

10.01

4.01

1.0

—

Asthma, excluding more controls

4.49

4.00

1.1

—

Disorders of choroid and retina

2.89

4.00

1.1

—

Stroke, excluding SAH

3.21

4.00

1.1

—

Sleep apnoea, including avohilmo

2.71

3.99

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.92

3.87

1.1

—

Used for control exclusion in common control thyroid runs

3.13

3.86

1.0

1.1

—

All influenza

7.28

3.85

1.0

—

Certain infectious and parasitic diseases

3.58

3.85

1.1

1.0

—

Stroke, including SAH

3.10

3.80

1.1

—

All kidney diseases

2.65

3.77

1.0

1.1

—

Other skin changes

8.76

3.77

1.1

1.0

—

Other intervertebral disc disorders

3.07

3.76

1.0

1.1

—

Nephropathy related operations

12.01

3.76

1.0

—

Candidiasis

12.01

3.76

1.2

1.0

—

Chronic lower respiratory diseases

2.48

3.71

1.1

1.0

—

Mycoses, including avohilmo

2.62

3.65

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

5.65

3.63

1.0

—

Intracranial trauma

6.08

3.57

1.0

—

Asthma (diagnoses ohter than nonallergic)

2.64

3.57

1.1

—

Other medical care

4.03

3.52

1.1

1.0

—

Sulfasalazine

6.16

3.50

1.0

1.1

—

Tumor necrosis factor alpha inhibitors

10.01

3.49

1.0

—

Other disorders of urethra and urinary system

3.07

3.49

1.1

—

Ischaemic Stroke, excluding all haemorrhages

3.12

3.40

1.1

—

Caries of dentine

5.93

3.40

1.1

—

Type 2 diabetes

2.68

3.36

1.1

—

Cellulitis

7.00

3.36

1.1

—

Hypo-osmolality and hyponatraemia

8.51

3.24

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

3.12

3.24

1.0

1.1

—

Oxycodone

3.66

3.24

1.0

1.2

—

Organic, including symptomatic, mental disorders

3.52

3.23

1.0

—

Dental caries

5.39

3.18

1.1

—

Intestinal stricture

4.50

3.11

1.0

1.1

—

Osteopathies and chondropathies

2.97

3.09

1.1

—

Episodal and paroxysmal disorders

2.68

3.08

1.1

1.0

—

Dizziness and giddiness

2.78

3.07

1.0

1.1

—

Persons encountering health services in other circumstances

3.39

3.06

1.0

1.1

—

Other viral diseases, not elsewhere classified

7.48

3.04

1.0

—

Lower back pain or/and sciatica

2.37

3.02

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2.42

3.02

1.1

—

Tramadol

2.75

3.00

1.0

1.1

—

Allergic asthma (mode)

7.32

3.00

1.0

1.1

—

Allergic asthma (mode), excluding more controls

7.32

3.00

1.0

1.1

—

Spondylopathies

2.86

2.99

1.0

1.1

—

Osteoporosis

5.85

2.98

1.0

1.1

—

Herpesviral [herpes simplex] infections

10.01

2.98

1.0

—

Sarcoidosis

10.01

2.98

1.2

1.0

—

Other disorders of eye and adnexa

10.01

2.98

1.0

—

Other diseases of intestines

2.42

2.92

1.1

—

Non-small cell lung cancer, including Hilmo

7.04

2.92

1.0

—

Lung cancer and mesothelioma

7.27

2.91

1.0

—

Diabetes medication

2.46

2.91

1.1

—

7.00

2.91

1.2

1.0

—

Rheumatoid arthritis, including avohilmo

4.09

2.88

1.0

1.1

—

Fracture of skull and facial bones

5.39

2.86

1.0

1.1

—

Acute appendicitis, with complications

6.67

2.86

1.2

1.0

—

Syncope and collapse

4.17

2.85

1.1

—

Other diseases of upper respiratory tract

2.47

2.84

1.1

—

Insulin medication

2.84

2.81

1.1

—

Abnormal findings on diagnostic imaging of lung

3.36

2.81

1.0

1.1

—

Other diseases of urinary system

2.42

2.79

1.0

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

2.84

2.79

1.1

—

Problems related to lifestyle

8.34

2.75

1.0

—

Diseases of oesophagus, stomach and duodenum

2.31

2.72

1.1

—

COPD/asthma related infections

2.67

2.72

1.1

—

COPD/asthma/ILD related infections

2.67

2.72

1.1

—

Other and unspecified dermatitis

2.71

1.1

—

Fall on same level

2.28

2.70

1.0

1.1

—

Gastric ulcer

6.00

2.69

1.0

—

Convulsions, not elsewhere classified

5.93

2.67

1.0

1.1

—

Rheumatoid arthritis

3.79

2.65

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

3.11

2.63

1.2

1.1

—

Paralytic ileus and intestinal obstruction

4.66

2.59

1.0

1.1

—

Infections with a predominantly sexual mode of transmission

4.66

2.59

1.1

—

Other viral diseases, not elsewhere classified, including avohilmo

4.64

2.58

1.0

1.1

—

Medical observation and evaluation for suspected diseases and conditions

3.07

2.56

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

2.60

2.52

1.2

1.1

—

Other dorsopathies, not elsewhere classified

2.45

2.52

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2.40

2.51

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.62

2.51

1.1

—

Intestinal infectious diseases

2.27

2.50

1.1

—

Other retinal disorders

2.67

2.49

1.1

—

Non-invasive ventilation

7.19

2.49

1.2

1.0

—

Cough

3.22

2.48

1.0

1.2

—

Acute tubulo-interstitial nephritis

2.61

2.46

1.0

1.1

—

Hard cardiovascular diseases

2.53

2.45

1.1

—

Malignant neoplasm

2.51

2.41

1.0

1.1

—

Malignant neoplasm

2.51

2.41

1.0

1.1

—

Menorrhagia

4.88

2.41

1.0

—

Crohn disease

6.25

2.37

1.0

—

Fentanyl

6.24

2.37

1.0

—

Other systemic involvement of connective tissue (FG)

4.91

2.36

1.2

—

Injuries to the head

2.16

2.36

1.0

1.1

—

Other arthritis (FG)

3.64

2.36

1.0

1.1

—

Complications of surgical and medical care, not elsewhere classified

2.22

2.34

1.1

—

Dermatitis

2.49

2.33

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

2.40

2.32

1.1

—

Migraine

3.33

2.31

1.0

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

4.11

2.29

1.0

—

Herpesviral [herpes simplex] infections, including avohilmo

4.62

2.27

1.0

—

Other systemic involvement of connective tissue

4.62

2.27

1.2

1.1

—

Pulmonary embolism

4.62

2.27

1.0

—

Pulmonary heart disease

4.62

2.27

1.0

—

Malignant neoplasm, including Hilmo

2.43

2.27

1.0

1.1

—

Cervical disc disorders

3.48

2.26

1.0

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

3.48

2.26

1.1

—

Malignant neoplasm, wide definition

2.42

2.26

1.0

1.1

—

Codeine or tramadol medication

2.13

2.25

1.0

1.1

—

Other (not insulin) diabetes medications

2.27

2.24

1.1

—

Other/unspecified dorsalgia

3.44

2.23

1.0

1.1

—

GASTRO-related operations

3.47

2.22

1.0

—

Any gastric operation

3.47

2.22

1.0

—

Other (seronegative) rheumatoid arthritis, wide

5.56

2.21

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

5.56

2.21

1.4

1.0

—

Hyperparathyroidism

5.50

2.19

1.0

—

Disorders of parathyroid gland

5.49

2.19

1.0

—

Pollen allergy

5.48

2.19

1.2

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2.83

2.17

1.0

1.1

—

Complications of medical and surgical care

2.33

2.16

1.1

—

Chronic sinusitis

3.00

2.14

1.0

1.1

—

Disorders of other endocrine glands

3.28

2.14

1.0

1.1

—

2.14

2.13

1.1

—

DVT of lower extremities and pulmonary embolism

2.99

2.13

1.0

1.1

—

Other diseases of pleura

2.80

2.12

1.2

1.0

—

Other and unspecified tonsillitis

3.32

2.12

1.0

1.1

—

Chronic periodontitis, including avohilmo

2.13

2.11

1.1

—

Periodontitis

2.12

2.11

1.1

—

Hyperlipidaemia, other/unspecified

3.27

2.10

1.0

1.2

—

Aplastic and other anaemias

2.77

2.10

1.1

—

Disorders of sclera, cornea, iris and ciliary body

2.45

2.10

1.1

—

Glomerular diseases

5.00

2.07

1.0

—

Substance use, excluding alcohol

5.00

2.07

1.2

1.1

—

Acute renal failure

4.00

2.04

1.0

—

Chronic gastritis

4.00

2.04

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

2.36

2.02

1.1

—

Solid cancers

2.34

2.00

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

3.03

2.00

1.0

1.1

—

Other functional intestinal disorders

2.82

1.98

1.0

1.1

—

Excessive, frequent and irregular menstruation

3.74

1.96

1.0

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

3.33

1.96

1.0

1.1

—

Symptoms and signs involving the urinary system

2.25

1.94

1.1

—

Type 1 diabetes

4.54

1.94

1.0

—

Obesity related asthma

2.96

1.93

1.0

1.1

—

Malignant neoplasm of bronchus and lung, including Hilmo

3.85

1.92

1.0

—

Other soft tissue disorders, not elsewhere classified

2.17

1.92

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

2.14

1.92

1.0

1.1

—

Infections of the skin and subcutaneous tissue

2.31

1.88

1.1

—

Other reaction to severe stress, and adjustment disorders

3.18

1.87

1.0

—

Temporomandibular joint disorders, including avohilmo

2.87

1.86

1.0

1.1

—

Extrapyramidal and movement disorders

2.86

1.86

1.1

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

2.06

1.85

1.1

—

Erysipelas

2.87

1.84

1.0

—

Codeine

2.19

1.83

1.0

1.1

—

Nerve, nerve root and plexus disorders

2.00

1.82

1.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

4.17

1.82

1.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis

4.17

1.82

1.0

1.1

—

Seropositive rheumatoid arthritis, wide

4.17

1.82

1.0

1.1

—

Sequelae of cerebrovascular disease

2.85

1.82

1.1

1.0

—

Diabetic neuropathy

4.15

1.81

1.0

1.1

—

Seropositive rheumatoid arthritis

4.14

1.81

1.0

1.2

—

Allergic rhinitis

3.48

1.81

1.2

1.1

—

COPD (mode)

4.33

1.80

1.4

1.1

—

Spinal stenosis

2.65

1.80

1.0

1.1

—

Other specified/unspecified arthritis

3.04

1.79

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions

2.76

1.78

1.0

1.1

—

Dementia

2.88

1.78

1.0

1.1

—

Infections with a predominantly sexual mode of transmission, including avohilmo

3.05

1.78

1.1

—

Malignant neoplasm of bronchus and lung

4.18

1.78

1.0

—

Any event in cancer register

2.21

1.78

1.0

1.1

—

3.44

1.76

1.2

1.0

—

Type 2 diabetes, definitions combined

2.13

1.75

1.1

—

Persons encountering health services in other circumstances, wide

1.95

1.75

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

3.33

1.74

1.0

1.1

—

Biguanides

2.05

1.74

1.1

—

Pain in throat and chest

2.18

1.74

1.0

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

2.11

1.73

1.1

—

Deviated nasal septum

2.91

1.72

1.0

1.1

—

Acute suppurative otitis media

3.29

1.71

1.0

1.1

—

Any reimbursement code in KELA

3.19

1.69

1.0

—

Dyspnoea

2.04

1.68

1.0

1.1

—

Hypertension, essential

2.23

1.67

1.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

2.08

1.67

1.1

—

Gastroduodenal ulcer

3.15

1.65

1.0

—

Other anxiety disorders

2.62

1.65

1.1

—

Conjunctivitis (acute, non atopic)

3.14

1.65

1.0

1.1

—

Cardiac arrhythmias

2.70

1.65

1.1

1.0

—

Fracture of rib(s), sternum and thoracic spine

2.80

1.65

1.0

1.1

—

Other respiratory disorders and diseases

3.57

1.61

1.4

1.0

—

Other diseases of the respiratory system

3.57

1.61

1.4

1.0

—

Vasomotor and allergic rhinitis

2.74

1.60

1.1

—

Inflammatory bowel disease

3.00

1.58

1.0

1.1

—

Insulin, intermediate and long-acting

2.30

1.56

1.1

—

Erysipelas, including avohilmo

2.31

1.55

1.0

—

Lumbar disc prolapse

2.31

1.55

1.0

1.1

—

Disorders of vestibular function (Vertigo)

2.43

1.54

1.1

1.0

—

COPD differential diagnosis

2.65

1.54

1.0

1.1

—

ILD differential diagnosis

2.65

1.54

1.0

1.1

—

Excluding asthma or asthma-COPD overlap

2.65

1.54

1.0

1.1

—

Other pulmonary diagnosis

2.65

1.54

1.0

1.1

—

Other disorders of eyelid

2.43

1.53

1.0

1.1

—

Psychiatric diseases

2.03

1.53

1.1

—

Other antidepressants

1.93

1.53

1.1

—

Asthma, including avohilmo

1.83

1.52

1.1

—

Dementia, including avohilmo

2.56

1.51

1.1

1.0

—

Insulin, fast-acting

2.59

1.51

1.0

—

Non-ischemic cardiomyopathy

2.64

1.50

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

2.86

1.50

1.2

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

2.86

1.50

1.2

1.1

—

Nausea and vomiting

3.25

1.48

1.0

1.1

—

Hypertensive diseases (excluding secondary)

2.71

1.48

1.0

1.1

—

Substance abuse, excluding more controls

2.26

1.46

1.1

—

Heart failure,strict

2.41

1.46

1.0

1.2

—

Retinal detachments and breaks

2.50

1.45

1.0

1.1

—

Valvular heart disease excluding rheumatic fever

2.38

1.44

1.0

1.1

—

Non-rheumatic valve diseases

2.38

1.44

1.0

1.1

—

Leiomyoma of uterus

2.40

1.44

1.0

1.1

—

Bronchitis

1.85

1.44

1.1

—

Benign paroxysmal vertigo

3.13

1.44

1.2

1.1

—

Irritable bowel syndrome

3.13

1.44

1.0

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

3.19

1.43

1.0

—

Finngen Rheumatological endpoints

1.99

1.41

1.1

—

Inflammatory diseases of female pelvic organs

2.28

1.39

1.1

1.0

—

Insulin, fast-acting or short human

2.41

1.39

1.0

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

1.97

1.36

1.2

1.1

—

Blepharochalasis

2.94

1.36

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

2.94

1.36

1.2

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.85

1.34

1.0

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.18

1.34

1.0

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

2.66

1.33

1.0

1.1

—

Cardiovascular diseases

2.50

1.32

1.0

1.1

—

Diseases of inner ear

2.13

1.32

1.1

—

Zoster [herpes zoster], including avohilmo

2.12

1.31

1.0

1.1

—

Other and unspecified anaemias

2.42

1.31

1.1

—

Other anaemias

2.41

1.30

1.1

—

All-cause Heart Failure

2.17

1.30

1.0

1.1

—

Meniscus derangement

2.13

1.29

1.2

1.1

—

Polycystic ovarian syndrome, consortium definition

2.21

1.29

1.1

1.0

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

3.05

1.29

1.0

1.1

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1.79

1.28

1.1

—

Polyuria

2.78

1.28

1.0

—

Disturbances of skin sensation

2.78

1.28

1.0

1.1

—

Examination and observation for other reasons

2.37

1.28

1.1

—

Solid cancers, including Hilmo

2.00

1.24

1.0

1.1

—

Other enthesopathies

2.40

1.24

1.0

1.2

—

Venous thromboembolism

2.01

1.24

1.0

1.1

—

Calcific aortic valvular stenosis, operated

2.67

1.23

1.0

—

Calcific aortic valvular stenosis

2.67

1.23

1.0

—

Operations 2 for CAVS

2.67

1.23

1.0

—

Calcific aortic valvular stenosis, diagnosis (helper)

2.67

1.23

1.0

—

Calcific aortic valvular stenosis, including rheumatic fever

2.67

1.23

1.0

—

Hypertensive diseases

1.99

1.22

1.0

1.1

—

Hypertension

1.99

1.22

1.0

1.1

—

Heart failure, strict

2.11

1.22

1.0

1.1

—

Psoriasis

2.63

1.21

1.0

1.1

—

Dermatitis and eczema

1.73

1.20

1.1

—

Spondylosis

2.15

1.19

1.0

1.1

—

Periapical abscess

2.11

1.18

1.0

1.1

—

Benign thyroid growths and nodules

2.58

1.18

1.0

1.1

—

Suppurative and unspecified otitis media

2.31

1.17

1.0

—

Parasetamol

2.53

1.16

1.0

1.1

—

Acute sinusitis

2.08

1.16

1.1

—

Obesity and other hyperalimentation

2.00

1.15

1.0

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

2.03

1.14

1.0

1.1

—

Degeneration of macula and posterior pole

2.06

1.14

1.1

—

Injuries to the knee and lower leg

1.68

1.12

1.1

—

Other heart diseases, wide

1.80

1.12

1.1

—

Obesity due to excess calories

2.00

1.12

1.0

1.1

—

Asthma/COPD (KELA code 203)

1.76

1.08

1.1

1.0

—

Excessive attrition of teeth

1.94

1.08

1.1

—

Other symptoms and signs involving the nervous and musculoskeletal systems

2.19

1.08

1.3

1.1

—

Certain infectious and parasitic diseases, including avohilmo

2.19

1.05

1.0

1.1

—

Urinary track infection

2.19

1.05

1.0

1.1

—

Other acute lower respiratory infections

1.99

1.04

1.0

1.1

—

Gingivitis and periodontal diseases

1.81

1.03

1.0

1.1

—

Appendicitis, broad definition

1.79

1.03

1.1

—

Intracranial injury

1.95

1.03

1.0

1.1

—

Other headache syndromes

2.26

1.03

1.0

—

Hypothyroidism, strict autoimmune

2.09

1.02

1.0

1.1

—

Diseases of appendix

1.79

1.02

1.1

—

Acute upper respiratory infections

1.70

1.01

1.1

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

2.25

1.01

1.4

1.0

—

Pain in limb

1.81

1.00

1.0

1.1

—

Use of anticholinesterases

2.27

1.00

1.0

—

N06DA Anticholinesterases

2.27

1.00

1.0

—

Tonsillectomy and adenotomy

2.03

0.99

1.0

—

Any mental disorder

1.71

0.99

1.1

—

Chronic apical periodontitis

1.66

0.99

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.84

0.98

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.83

0.98

1.1

—

All anxiety disorders

1.84

0.98

1.1

—

Obesity

1.80

0.96

1.0

1.1

—

Substance abuse

1.86

0.96

1.1

—

Abdominal and pelvic pain

1.71

0.94

1.0

1.1

—

Noninfective enteritis and colitis

1.89

0.94

1.0

1.1

—

Conjunctivitis (acute, non atopic), including avohilmo

1.65

0.92

1.1

—

Recurrent or chronic depression

2.19

0.92

1.2

1.1

—

Cystitis

1.82

0.92

1.0

1.1

—

Glaucoma suspect

2.14

0.91

1.0

1.1

—

Abnormalities of breathing

1.76

0.91

1.0

1.1

—

Acute bronchitis

2.10

0.90

1.0

1.1

—

Disorders of conjunctiva

1.68

0.90

1.1

—

Mental and behavioural disorders due to psychoactive substance use

1.80

0.87

1.1

—

Unspecific neurodegenerative disorder

2.05

0.87

1.0

1.1

—

Internal derangement of knee

1.98

0.86

1.2

1.1

—

Disorders of vitreous body

1.81

0.85

1.0

1.1

—

Anxiety disorders, excluding more controls

1.76

0.85

1.1

—

Disorders of vitreous body and globe

1.80

0.85

1.0

1.1

—

Iron deficiency anaemia

1.90

0.82

1.0

—

Other nutritional deficiencies

1.76

0.82

1.0

1.1

—

Acute appendicitis

1.70

0.82

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.59

0.81

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

1.72

0.81

1.0

1.1

—

Dental operations

1.93

0.81

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

1.75

0.77

1.1

—

1.80

0.77

1.3

1.0

—

Hallux valgus (acquired)

2.23

0.77

1.2

1.1

—

Anxiety (asthma-related co-morbidities)

1.75

0.77

1.1

—

Benzodiazepine use

1.57

0.77

1.1

—

Other diseases of lip and oral mucosa

1.76

0.76

1.2

1.1

—

Other heart diseases

2.17

0.76

1.0

1.1

—

Any dementia

2.16

0.76

1.0

—

Alcohol use disorder, Swedish definition

1.70

0.75

1.0

1.1

—

Chronic diseases of tonsils and adenoids

1.67

0.75

1.1

—

Exposure to other specified factors

1.61

0.74

1.1

—

Urticaria and erythema

2.08

0.74

1.0

—

Disorders of the thyroid gland

1.59

0.74

1.0

1.1

—

Gastro-oesophageal reflux disease

1.65

0.74

1.1

—

Nutritional anaemias

1.85

0.73

1.0

1.1

—

Alcohol use disorder, ICD-based

1.84

0.73

1.0

1.1

—

Injuries to the thorax

1.84

0.73

1.0

1.1

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1.81

0.72

1.1

—

Diseases of liver

2.00

0.72

1.0

1.1

—

Myocardial infarction, strict

1.77

0.71

1.1

—

Persons encountering health services for examination and investigation

1.76

0.71

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

1.59

0.70

1.0

1.1

—

1.56

0.70

1.0

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.69

0.69

1.0

1.1

—

Other benign neoplasms of skin

1.85

0.68

1.2

1.0

—

Use of hypnotics and sedatives

1.50

0.67

1.0

1.1

—

Antihypertensive medication - note that there are other indications

1.66

0.67

1.0

—

Actinic keratosis

1.82

0.67

1.4

1.0

—

Neurotic, stress-related and somatoform disorders

1.56

0.65

1.1

—

Anxiety disorders

1.55

0.64

1.1

—

Abnormalities of heart beat

1.73

0.64

1.0

1.1

—

Allergic conjunctivitis

1.57

0.63

1.1

—

COPD, hospital admission 2, with asthma infections

1.72

0.63

1.4

1.0

—

Major coronary heart disease event excluding revascularizations

1.65

0.63

1.1

—

Glaucoma

1.66

0.62

1.0

1.1

—

Conjunctivitis

1.61

0.62

1.1

—

Any dementia, excluding more controls

1.72

0.62

1.0

1.1

—

Diaphragmatic hernia

1.67

0.61

1.0

1.1

—

Bleeding

1.53

0.61

1.0

1.1

—

Other disorders of skin and subcutaneous tissue

1.59

0.61

1.2

1.1

—

Mental and behavioural disorders due to alcohol

1.59

0.61

1.0

1.1

—

Statin medication

1.55

0.60

1.0

—

L02BG Aromatase inhibitors

0.00

0.59

0.0

1.1

—

Diverticular disease of intestine

1.51

0.58

1.1

—

Chronic periodontitis, complicated

1.50

0.58

1.1

—

Other and unspecified disorders of vitreous body

1.73

0.58

1.0

1.1

—

Sciatica+with lumbago

1.71

0.57

1.0

1.1

—

Appendectomy

1.49

0.57

1.1

—

Myocardial infarction, without ST-elevation

1.69

0.57

1.2

1.1

—

Diseases of the respiratory system

1.67

0.57

1.0

1.1

—

Sleep disorders (combined)

1.46

0.56

1.2

1.0

—

Other specific joint derangements/joint disorders

1.56

0.56

1.0

1.1

—

1.46

0.56

1.0

1.1

—

Coxarthrosis [arthrosis of hip](FG)

1.59

0.54

1.0

1.1

—

Falls/tendency to fall

1.50

0.54

1.1

—

Artificial joint operation, meniscal resection

1.48

0.52

1.2

1.1

—

Disorders of skin appendages

1.53

0.52

1.3

1.1

—

Emergency coronary revascularization (for ACS)

1.51

0.52

1.1

—

Transient ischemic attack

1.49

0.51

1.0

1.1

—

Open wound of head

1.48

0.51

1.0

1.1

—

External causes of morbidity and mortality

1.59

0.50

1.0

—

Myocardial infarction

1.58

0.49

1.1

—

Diseases of the eye and adnexa

1.52

0.49

1.0

1.1

—

Medical abortion

1.52

0.48

1.0

1.1

—

Disorders of synovium and tendon

1.48

0.47

1.0

1.1

—

Mood disorders, excluding more controls

1.47

0.47

1.1

—

Angina pectoris

1.45

0.46

1.0

1.1

—

Other chronic obstructive pulmonary disease, including avohilmo

1.44

0.46

1.3

1.1

—

Benign neoplasm: Colon

1.43

0.46

1.1

—

Heart failure and bmi 25plus

1.67

0.44

1.0

1.2

—

Diseases of the skin and subcutaneous tissue

1.45

0.44

1.2

1.0

—

Other external causes of accidental injury

1.43

0.43

1.0

—

Basal cell carcinoma

1.62

0.43

1.2

1.1

—

Other arrhythmias

1.46

0.43

1.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1.62

0.43

1.0

1.1

—

Exposure to unspecified factor

1.38

0.43

1.2

1.0

—

Basal cell carcinoma, including Hilmo

1.61

0.43

1.2

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

1.61

0.43

1.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

1.62

0.43

1.4

1.0

—

Arthrosis

1.41

0.43

1.0

1.1

—

Papulosquamous disorders

1.61

0.43

1.0

1.1

—

Excessive earwax

1.45

0.43

1.0

1.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1.43

0.42

1.0

1.1

—

Other chronic obstructive pulmonary disease

1.57

0.42

1.4

1.0

—

Disorders of breast

1.57

0.42

1.2

1.0

—

Irregular menses

1.56

0.42

1.0

—

COPD

1.56

0.42

1.4

1.0

—

Acne, including avohilmo

0.00

0.41

0.0

1.0

—

Presence of cardiac and vascular implants and grafts

1.53

0.41

1.0

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.38

0.41

1.1

—

Ganglion

0.00

0.41

0.0

1.1

—

Complications predominantly related to the puerperium

0.00

0.41

0.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.41

0.41

1.0

1.1

—

Malignant neoplasm of skin

1.47

0.40

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

1.33

0.40

1.0

1.1

—

Malignant neoplasm of skin, including Hilmo

1.46

0.40

1.0

1.1

—

Shoulder lesions

1.38

0.39

1.0

1.1

—

Injury of muscle and tendon at shoulder and upper arm level

1.43

0.39

1.0

1.1

—

Complications of procedures, not elsewhere classified

1.37

0.38

1.0

1.1

—

Heart failure and coronary heart disease

1.40

0.38

1.0

—

Sensorineural hearing loss

1.42

0.38

1.1

—

Major coronary heart disease event

1.31

0.38

1.1

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1.52

0.37

1.0

1.1

—

Coxarthrosis

1.49

0.37

1.0

1.1

—

Pain in joint

1.47

0.36

1.0

1.1

—

Peripheral artery disease

1.48

0.36

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.41

0.35

1.0

1.1

—

Other arthrosis

1.39

0.35

1.0

1.1

—

Conductive and sensorineural hearing loss

1.38

0.34

1.1

—

Constipation

1.35

0.34

1.1

—

Unspecified fall

1.34

0.34

1.0

1.1

—

Hypothyroidism, other/unspecified

1.37

0.32

1.0

1.1

—

Coxarthrosis, primary

1.35

0.31

1.0

1.1

—

Dorsopathies

1.37

0.31

1.0

1.1

—

Fall on same level involving ice and snow

1.32

0.30

1.0

1.1

—

Caries of enamel

1.31

0.30

1.1

—

Ischemic heart diseases

1.35

0.30

1.1

—

Dermatophytosis, including avohilmo

1.27

0.30

1.0

1.1

—

Ischaemic heart disease, wide definition

1.26

0.26

1.1

—

Opioids

1.22

0.26

1.0

1.1

—

Diseases of the ear and mastoid process

1.25

0.24

1.1

—

Gastrointestinal diseases

1.32

0.24

1.0

—

COPD related to multimorbidity

1.32

0.23

1.4

1.0

—

Unspecified haematuria

1.31

0.23

1.2

1.1

—

Disorders of gallbladder, biliary tract and pancreas

0.73

0.23

1.0

1.1

—

COPD, hospital admissions

1.28

0.23

1.4

1.0

—

Selective serotonin reuptake inhibitors

1.27

0.23

1.1

—

COPD, early/later onset

1.27

0.22

1.4

1.0

—

Coxarthrosis, primary, with hip surgery

1.25

0.22

1.0

1.1

—

Other menopausal disorders

0.00

0.22

0.0

1.0

—

Injuries to the hip and thigh

1.24

0.22

1.2

1.1

—

Uterine polyps

0.00

0.22

0.0

1.0

—

Mood [affective] disorders

1.24

0.21

1.1

1.0

—

Long labour

0.00

0.21

0.0

1.0

—

Mood disorders

1.24

0.21

1.1

1.0

—

Acute nasopharyngitis (common cold)

0.00

0.21

0.0

1.1

—

Valvular operations

0.00

0.21

0.0

1.0

—

HSIL lesion of the cervix uteri, vagina or vulva

0.00

0.21

0.0

1.0

—

Supervision of normal pregnancy

0.00

0.21

0.0

1.0

—

Endometriosis ASRM stages 3,4

0.00

0.21

0.0

1.1

—

Other hammer toe(s) (acquired)

0.00

0.21

0.0

1.1

—

Pain (limb, back, neck, head abdominally)

1.25

0.21

1.0

1.1

—

Complications of labour and delivery

1.23

0.20

1.0

1.1

—

Impacted teeth

0.00

0.20

0.0

1.0

—

Benign neoplasms

1.26

0.20

1.1

1.0

—

Depression or dysthymia

1.17

0.19

1.2

1.1

—

Accidents

1.25

0.19

1.0

—

Injuries to the shoulder and upper arm

1.24

0.19

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

1.22

0.18

1.0

1.1

—

Depression

1.22

0.18

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.74

0.17

1.0

1.1

—

Triptan medication for migraine, single purchase ok

0.74

0.17

1.0

1.1

—

Percutaneous Coronary Intervention

1.19

0.17

1.1

—

Coronary revascularization (ANGIO or CABG)

1.18

0.17

1.1

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.14

0.16

1.0

1.1

—

Injuries to the ankle and foot

1.16

0.16

1.0

1.1

—

Other disorders of ear

1.17

0.11

1.1

—

Diseases of pulp and periapical tissues and dental caries

1.17

0.10

1.0

1.1

—

Other maternal disorders predominantly related to pregnancy

1.16

0.10

1.0

1.1

—

Triptan medication for migraine, min. 3 purchases

1.13

0.10

1.0

1.1

—

Abnormal findings on examination of blood, without diagnosis

1.13

0.10

1.0

1.1

—

Acute appendicitis, no complications

1.13

0.10

1.0

1.1

—

Dental caries, including avohilmo

1.07

0.09

1.0

1.1

—

Neoplasms

1.05

0.09

1.0

—

Diseases of middle ear and mastoid

1.05

0.09

1.0

1.1

—

Gonarthrosis

1.13

0.09

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

1.13

0.09

1.2

1.1

—

Carpal tunnel syndrome

1.11

0.09

1.0

1.1

—

Coronary atherosclerosis

1.08

0.09

1.2

1.1

—

Inguinal hernia

1.08

0.09

1.0

1.1

—

Artrosis, including avohilmo

1.07

0.07

1.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.03

0.07

1.0

1.1

—

Soft tissue disorders

1.10

0.07

1.0

1.1

—

Gonarthrosis,primary

1.08

0.07

1.1

—

Hernia

1.03

0.07

1.0

1.1

—

Insomnia

1.03

0.07

1.1

1.0

—

Dental pulpitis, including avohilmo

0.87

0.07

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.86

0.07

1.0

1.1

—

Injuries to the wrist and hand

0.89

0.06

1.2

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

1.05

0.00

1.1

—

Cardiomyopathies, Primary/intrinsic

0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

0.0

1.0

—

Benign neoplasm of meninges

0.00

0.0

1.0

—

Superficial injury of shoulder and upper arm

0.00

0.0

1.0

—

Acne vulgaris

0.00

0.0

1.0

—

Mixed conductive and sensorineural hearing loss

0.00

0.0

1.0

—

Ménière disease

0.00

0.0

1.0

—

Thyroiditis, ILD-related definition

0.00

-0.00

0.0

1.0

—

Pleural plaque

0.00

-0.00

0.0

1.0

—

Nonischemic cardiomyopathy

0.00

-0.00

0.0

1.0

—

Normotensive glaucoma

0.00

-0.00

0.0

1.0

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

-0.00

0.0

1.0

—

Varicose veins

0.97

-0.00

1.0

1.1

—

Crowding of teeth, including avohilmo

0.00

-0.00

0.0

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

-0.00

0.0

1.0

—

Pregnancy with abortive outcome

1.00

-0.00

1.0

1.1

—

Otitis media, unspecified

0.00

-0.00

0.0

1.0

—

Other diseases of biliary tract

0.00

-0.00

0.0

1.0

—

HSIL lesion of the cervix uteri

0.00

-0.00

0.0

1.0

—

Coeliac disease

0.00

-0.00

0.0

1.0

—

Injuries to the elbow and forearm

0.89

-0.00

1.0

1.1

—

Chronic pancreatitis

0.00

-0.00

0.0

1.0

—

Acne

0.00

-0.00

0.0

1.0

—

Allergic contact dermatitis

0.00

-0.00

0.0

1.0

—

Pedal cyclist injured in noncollision transport accidents

0.00

-0.00

0.0

1.0

—

Toxic effects of substances chiefly nonmedicinal as to source

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

-0.00

0.0

1.0

—

Benign neoplasm of major salivary glands

0.00

-0.00

0.0

1.0

—

Superficial injury of ankle and foot

0.00

-0.00

0.0

1.0

—

Other diseases of oesophagus

0.00

-0.00

0.0

1.0

—

Macular pucker

0.00

-0.00

0.0

1.0

—

Idiopathic gout

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at wrist and hand level

0.00

-0.00

0.0

1.0

—

Other female pelvic inflammatory diseases

0.00

-0.00

0.0

1.1

—

Perineal laceration during delivery

0.00

-0.00

0.0

1.0

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.0

—

Multiple gestation

0.00

-0.00

0.0

1.0

—

Other benign neoplasms of connective and other soft tissue

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs, including Hilmo

0.00

-0.00

0.0

1.3

—

Other disorders of cornea

0.00

-0.00

0.0

1.0

—

Early lumbar disc prolapse operation

0.00

-0.00

0.0

1.0

—

Emotionally unstable personality disorder

0.00

-0.00

0.0

1.0

—

Monoamine oxidase A inhibitors

0.00

-0.00

0.0

1.0

—

Other disorders of the genitourinary system

0.00

-0.00

0.0

1.0

—

Puerperal sepsis

0.00

-0.00

0.0

1.1

—

Other joint disorders

0.99

-0.00

1.1

—

Prolonged pregnancy

0.00

-0.00

0.0

1.0

—

Premature rupture of membranes

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.1

—

Postpartum haemorrhage due to retained placenta

0.00

-0.00

0.0

1.0

—

Sequelae of injuries of upper limb

0.00

-0.00

0.0

1.0

—

Dilated cardiomyopathy

0.00

-0.00

0.0

1.0

—

Disorder of lipoprotein metabolism, unspecified

0.00

-0.00

0.0

1.0

—

Amiodarone users

0.00

-0.00

0.0

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.95

-0.00

1.1

1.0

—

Twin gestation

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Persons encountering health services in circumstances related to reproduction

0.91

-0.00

1.2

1.1

—

Non-allergic asthma (mode)

0.00

-0.00

0.0

1.0

—

Other local infections of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Caries of dentine, including avohilmo

0.91

-0.00

1.0

1.1

—

Sleep disorders

0.98

-0.00

1.1

1.0

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.0

—

Ascites

0.00

-0.00

0.0

1.0

—

Other disorders of amniotic fluid and membranes

0.00

-0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other diseases of pancreas

0.00

-0.00

0.0

1.0

—

Other/unspecified synovitis and tenosynovitis

0.00

-0.00

0.0

1.0

—

Polycystic ovarian syndrome, broad definition

0.00

-0.00

0.0

1.0

—

Assault by bodily force

0.00

-0.00

0.0

1.0

—

Vitamin B12 deficiency anaemia

0.00

-0.00

0.0

1.0

—

Non-allergic asthma (mode), excluding more controls

0.00

-0.00

0.0

1.0

—

Conductive hearing loss, unspecified

0.00

-0.00

0.0

1.0

—

Superficial injury of thorax

0.00

-0.00

0.0

1.0

—

Endometriosis of ovary

0.00

-0.00

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

-0.00

0.0

1.0

—

Abdominal aortic aneurysm (AAA)

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS